Normal and neoplastic stem cells
26 Apr 2016
Normal and neoplastic stem cells
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers
Novel agents before and after stem cell transplantation for myeloma
EBMT 2016 Highlights: Expert discussion
Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer
Combination of viroimmunotherapy with checkpoint inhibitors
Hypoxia and its impact on the immune system
The role of microRNAs in modulation of the immune escape of tumors
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy
Biomarkers in t-cell therapy trials
Immunotherapy and personalised medicine in review